Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Outcomes of Tocilizumab for Cytokine Release Syndrome after Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: April 22, 2026
Phase I Trial of Venetoclax and BEAM Followed by Autologous Stem Cell Transplant for High-Risk Non-Hodgkin Lymphoma.
Journal: Transplantation and cellular therapy
Published: January 28, 2026
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation.
Journal: Journal of the American Heart Association
Published: September 19, 2025
Combination ruxolitinib, belumosudil, and axatilimab yields clinically significant symptomatic improvements in treatment-refractory chronic GVHD.
Journal: Bone marrow transplantation
Published: June 24, 2025
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.
Journal: Journal of hematology & oncology
Published: December 24, 2024
Impact of chronic graft-versus-host disease on non-relapse mortality and survival.
Journal: Leukemia & lymphoma
Published: June 12, 2024
Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance.
Journal: Transplantation and cellular therapy
Published: March 19, 2024
Dupilumab for refractory sclerotic-type cutaneous graft-versus-host disease.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 02, 2023
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.
Journal: Cancer medicine
Published: August 19, 2022
Prognostic value of early imaging following CAR-T cell therapy in diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: February 03, 2022
Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: December 20, 2021
Last Updated: 09/26/2026